BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 23502782)

  • 1. POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia.
    Ramsay AJ; Quesada V; Foronda M; Conde L; Martínez-Trillos A; Villamor N; Rodríguez D; Kwarciak A; Garabaya C; Gallardo M; López-Guerra M; López-Guillermo A; Puente XS; Blasco MA; Campo E; López-Otín C
    Nat Genet; 2013 May; 45(5):526-30. PubMed ID: 23502782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia.
    Speedy HE; Kinnersley B; Chubb D; Broderick P; Law PJ; Litchfield K; Jayne S; Dyer MJS; Dearden C; Follows GA; Catovsky D; Houlston RS
    Blood; 2016 Nov; 128(19):2319-2326. PubMed ID: 27528712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pot1 OB-fold mutations unleash telomere instability to initiate tumorigenesis.
    Gu P; Wang Y; Bisht KK; Wu L; Kukova L; Smith EM; Xiao Y; Bailey SM; Lei M; Nandakumar J; Chang S
    Oncogene; 2017 Apr; 36(14):1939-1951. PubMed ID: 27869160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The OB-fold domain 1 of human POT1 recognizes both telomeric and non-telomeric DNA motifs.
    Choi KH; Lakamp-Hawley AS; Kolar C; Yan Y; Borgstahl GEO; Ouellette MM
    Biochimie; 2015 Aug; 115():17-27. PubMed ID: 25934589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer chromosomes going to POT1.
    Chang S
    Nat Genet; 2013 May; 45(5):473-5. PubMed ID: 23619786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional analysis of the human POT1-TPP1 telomeric complex.
    Rice C; Shastrula PK; Kossenkov AV; Hills R; Baird DM; Showe LC; Doukov T; Janicki S; Skordalakes E
    Nat Commun; 2017 Apr; 8():14928. PubMed ID: 28393830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTOP interacts with POT1 and regulates its localization to telomeres.
    Liu D; Safari A; O'Connor MS; Chan DW; Laegeler A; Qin J; Songyang Z
    Nat Cell Biol; 2004 Jul; 6(7):673-80. PubMed ID: 15181449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct requirements for Pot1 in limiting telomere length and maintaining chromosome stability.
    Bunch JT; Bae NS; Leonardi J; Baumann P
    Mol Cell Biol; 2005 Jul; 25(13):5567-78. PubMed ID: 15964812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. POT1 mutations cause differential effects on telomere length leading to opposing disease phenotypes.
    Zade NH; Khattar E
    J Cell Physiol; 2023 Jun; 238(6):1237-1255. PubMed ID: 37183325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
    Shi J; Yang XR; Ballew B; Rotunno M; Calista D; Fargnoli MC; Ghiorzo P; Bressac-de Paillerets B; Nagore E; Avril MF; Caporaso NE; McMaster ML; Cullen M; Wang Z; Zhang X; ; ; ; Bruno W; Pastorino L; Queirolo P; Banuls-Roca J; Garcia-Casado Z; Vaysse A; Mohamdi H; Riazalhosseini Y; Foglio M; Jouenne F; Hua X; Hyland PL; Yin J; Vallabhaneni H; Chai W; Minghetti P; Pellegrini C; Ravichandran S; Eggermont A; Lathrop M; Peris K; Scarra GB; Landi G; Savage SA; Sampson JN; He J; Yeager M; Goldin LR; Demenais F; Chanock SJ; Tucker MA; Goldstein AM; Liu Y; Landi MT
    Nat Genet; 2014 May; 46(5):482-6. PubMed ID: 24686846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere status in chronic lymphocytic leukemia with TP53 disruption.
    Guièze R; Pages M; Véronèse L; Combes P; Lemal R; Gay-Bellile M; Chauvet M; Callanan M; Kwiatkowski F; Pereira B; Vago P; Bay JO; Tournilhac O; Tchirkov A
    Oncotarget; 2016 Aug; 7(35):56976-56985. PubMed ID: 27486974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy.
    Herling CD; Klaumünzer M; Rocha CK; Altmüller J; Thiele H; Bahlo J; Kluth S; Crispatzu G; Herling M; Schiller J; Engelke A; Tausch E; Döhner H; Fischer K; Goede V; Nürnberg P; Reinhardt HC; Stilgenbauer S; Hallek M; Kreuzer KA
    Blood; 2016 Jul; 128(3):395-404. PubMed ID: 27226433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomeric damage in early stage of chronic lymphocytic leukemia correlates with shelterin dysregulation.
    Augereau A; T'kint de Roodenbeke C; Simonet T; Bauwens S; Horard B; Callanan M; Leroux D; Jallades L; Salles G; Gilson E; Poncet D
    Blood; 2011 Aug; 118(5):1316-22. PubMed ID: 21355086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into POT1 structural dynamics revealed by cryo-EM.
    Smith EW; Lattmann S; Liu ZB; Ahsan B; Rhodes D
    PLoS One; 2022; 17(2):e0264073. PubMed ID: 35176105
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Shen E; Xiu J; Lopez GY; Bentley R; Jalali A; Heimberger AB; Bainbridge MN; Bondy ML; Walsh KM
    J Med Genet; 2020 Oct; 57(10):664-670. PubMed ID: 31937561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia.
    Poncet D; Belleville A; t'kint de Roodenbeke C; Roborel de Climens A; Ben Simon E; Merle-Beral H; Callet-Bauchu E; Salles G; Sabatier L; Delic J; Gilson E
    Blood; 2008 Feb; 111(4):2388-91. PubMed ID: 18077792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fission yeast Pot1-Tpp1 protects telomeres and regulates telomere length.
    Miyoshi T; Kanoh J; Saito M; Ishikawa F
    Science; 2008 Jun; 320(5881):1341-4. PubMed ID: 18535244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A
    Abu Shtaya A; Kedar I; Bazak L; Basel-Salmon L; Barhom SF; Naftali M; Eskin-Schwartz M; Birk OS; Polager-Modan S; Keidar N; Reznick Levi G; Levi Z; Yablonski-Peretz T; Mahamid A; Segol O; Matar R; Bareli Y; Azoulay N; Goldberg Y
    Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of telomeres 1 (POT1) of Pinus tabuliformis bound the telomere ssDNA.
    Luo M; Teng X; Wang B; Zhang J; Liu Y; Liu D; Li H; Lu H
    Tree Physiol; 2020 Jan; 40(1):119-127. PubMed ID: 31860719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POT1 loss-of-function variants predispose to familial melanoma.
    Robles-Espinoza CD; Harland M; Ramsay AJ; Aoude LG; Quesada V; Ding Z; Pooley KA; Pritchard AL; Tiffen JC; Petljak M; Palmer JM; Symmons J; Johansson P; Stark MS; Gartside MG; Snowden H; Montgomery GW; Martin NG; Liu JZ; Choi J; Makowski M; Brown KM; Dunning AM; Keane TM; López-Otín C; Gruis NA; Hayward NK; Bishop DT; Newton-Bishop JA; Adams DJ
    Nat Genet; 2014 May; 46(5):478-481. PubMed ID: 24686849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.